• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS 0.00% 8.0¢

VECTUS BIOSYSTEMS LIMITED

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VBS 31/10/24 0 148
31/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
VBS 28/10/24 0 165
28/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  165 
VBS 15/10/24 2 525
Industrials SECTOR NEWS

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

3DA
12 Nov 2024
AMAERO INTERNATIONAL LTD
15/10/24 Last post  Werble Comments Created with Sketch.  2  Views Created with Sketch.  525 
VBS 07/10/24 0 182
07/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  182 
VBS 07/10/24 0 158
07/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  158 
VBS 30/09/24 0 106
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  106 
VBS 30/09/24 0 268
30/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  268 
VBS 24/09/24 0 172
24/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  172 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities & Appendix 4C Cash Flow Reports
31 Oct 13:44
 
2024 Notice of AGM & Proxy Form
28 Oct 14:48
 
Date of 2024 Annual General Meeting
08 Oct 17:08
 
Cleansing Notice
07 Oct 19:59
 
Application for quotation of securities - VBS
07 Oct 19:53
 
2024 Corporate Governance Statement & Appendix 4G
30 Sep 18:47
 
View More arrow Created with Sketch.
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $4.260M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
VBS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.